Pten signalling in gliomas

Neuro-Oncology

Volumn 4, Issue 3, 2002, Pages 196-210

  Knobbe, Christiane B ^a   Merlo, Adrian ^a   Reifenberger, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GEMCITABINE; MOLECULAR MARKER; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN; RAPAMYCIN DERIVATIVE; RENIN; STAUROSPORINE; TEMSIROLIMUS; WORTMANNIN; AKT1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PTEN PROTEIN, HUMAN; TPTE PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL MODEL; APOPTOSIS; BRAIN DEVELOPMENT; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 10; CHROMOSOME ARM; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG METABOLISM; DRUG TARGETING; ENZYME ACTIVITY; GENE DELETION; GLIOBLASTOMA; GLIOMA; HUMAN; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PROGNOSIS; PROTEIN FUNCTION; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; BRAIN TUMOR; CELL DIVISION; CHEMISTRY; DRUG DESIGN; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 10; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR SUPPRESSOR PROTEINS;

EID: 0036660640     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851702000029     Document Type: Review

References (159)

1. Adey, N.B., Huang, L., Ormonde, P.A., Baumgard, M.L., Pero, R., Byreddy, D.V., Tavtigian, S.V, and Bartel, P.L. (2000) Threonine phosphorylation of the MMAC1/Pten PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res. 60, 35-37.
2. Agochiya, M., Brunton, V.G., Owens, D.W., Parkinson, E.K., Paraskeva, C., Keith, W.N., and Frame, M.C. (1999) Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18, 5646-5653.
3. Alessi, D.R., Kozlowski, M.T., Weng, Q.P, Morrice, N., and Avruch, J. (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8, 69-81.
4. Ali, I.U., Schriml, L.M., and Dean, M. (1999) Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity. J. Natl. Cancer Inst. 91, 1922-1932.
5. Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K., and Mizutani, S. (1999) Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. EMBO J. 18, 1223-1234.
6. Backman, S.A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.S., Shannon, P., Bolon, B., Ivy, G.O., and Mak, T.W. (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29, 396-403.
7. Blancher, C., Moore, J.W, Robertson, N., and Harris, A.L. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61, 7349-7355.
8. Borlado, L.R., Redondo, C., Alvarez, B., Jimenez, C., Criado, L.M., Flores, J., Marcos, M.A., Martinez, A.C., Balomenos, D., and Carrera. A.C. (2000) Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J. 14, 895-903.
9. Boström, J., Cobbers, J.M.J.L., Wolter, M., Tabatabai, G., Weber, R.G., Lichter, P., Collins, V.P., and Reifenberger, G. (1998) Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 58, 29-33.
10. Burgering, B.M., and Coffer, P.J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599-602.
11. Chen, H., Rossier, C., Morris, M.A., Scott, H.S., Gos, A., Bairoch, A., and Antonarakis, S.E. (1999) A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y. Hum. Genet. 105, 399-409.
12. Cheney, I.W., Johnson, D.E., Vaillancourt, M.T., Avanzini, J., Morimoto, A., Demers, G.W., Wills, K.N., Shabram, P.W., Bolen, J.B., Tavtigian, S.V, and Bookstein, R. (1998) Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58, 2331-2334.
13. Cheney, I.W., Neuteboom, S.T., Vaillancourt, M.T., Ramachandra, M., and Bookstein, R. (1999) Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res. 59, 2318-2323.
14. Cheng, J.Q., Godwin, A.K., Bellacosa, A., Taguchi, T, Franke, T.F., Hamilton, T.C., Tsichlis, P.N., and Testa, J.R. (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. U.S.A. 89, 9267-9271.
15. Cheng, J.Q., Ruggeri, B., Klein, W.M., Sonoda, G., Altomare, D.A., Watson, D.K., and Testa, J.R. (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. U.S.A. 93, 3636-3641.
16. Chiariello, E., Roz, L., Albarosa, R., Magnani, I., and Finocchiaro, G. (1998) PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 16, 541-545.
17. Chiariello, E., Roz, L., Albarosa, R., Magnani, I., and Finocchiaro, G. (1999) Identification of PTEN-related sequences in glioma cells and in non-neoplastic cell lines. Cancer Lett. 138, 1-4.
18. Dahia, P.L., FitzGerald, M.G., Zhang, X., Marsh, D.J., Zheng, Z., Pietsch, T, von Deimling, A., Haluska, F.G., Haber, D.A., and Eng, C. (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16, 2403-2406.
19. Davies, M.A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPushin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, WK., Mills, G.B., and Steck, P.A. (1998) Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58, 5285-5290.
20. Davies, M.P., Gibbs, F.E., Halliwell, N., Joyce, K.A., Roebuck, M.M., Rossi, M.L., Salisbury, J., Sibson, D.R., Tacconi, L., and Walker, C. (1999) Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. Br. J. Cancer 79, 1542-1548.
21. Di Cristofano, A., and Pandolfi, P.P. (2000) The multiple roles of Pten in tumor suppression. Cell 100, 387-390.
22. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P. (1998) Pten is essential for embryonic development and tumor suppression. Nat. Genet. 19, 348-355.
23. +/- mice. Science 285, 2122-2125.
24. KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet. 27, 222-224.
25. Duerr, E.M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlitz, B., Louis, D.N., Schramm, J., Wiestler, O.D., Parsons, R., Eng, C., and von Deimling, A. (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16, 2259-2264.
26. Ebert, C., von Haken, M., Meyer-Puttlitz, B., Wiestler, O.D., Reifenberger, G., Pietsch, T., and von Deimling, A. (1999) Molecular genetic analysis of ependymal tumors: NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am. J. Pathol. 155, 627-632.
27. Forgacs, E., Biesterveld, E.J., Sekido, Y., Fong, K., Muneer, S., Wistuba, I.I., Milchgrub, S., Brezinschek, R., Virmani, A., Gazdar, A.F., and Minna, J.D. (1998) Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene 17, 1557-1565.
28. Franke, T.F., Yang, S.I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K., Kaplan, D.R., and Tsichlis, P.N. (1995) The protein kinase encoded by the AKT proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736.
29. Fujii, G.H., Morimoto, A.M., Berson, A.E., and Bolen, J.B. (1999) Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene 18, 1765-1769.
30. Fults, D., and Pedone, C. (2000) Immunocytochemical mapping of the phosphatase and tensin homolog (Pten/MMAC1) tumor suppressor protein in human gliomas. Neuro-Oncology [serial online], Doc. 99-28, March 22, 2000. URL. Neuro-Oncology 2, 71-79.
31. Furnari, F.B., Lin, H., Huang, H.S., and Cavenee, W.K. (1997) Growth suppression of glioma cells by Pten requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. U.S.A. 94, 12479-12484.
32. 1 growth arrest in glioma cells. Cancer Res. 58, 5002-5008.
33. Kip1 expression by contact inhibition as a prognostic index of human glioma. J. Neurochem. 74, 1393-1399.
34. Geoerger, B., Kerr, K., Tang, C.B., Fung, K.M., Powell, B., Sutton, L.N., Phillips, P.C., and Janss, A.J. (2001) Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Res. 61, 1527-1532.
35. Georgescu, M.M., Kirsch, K.H., Akagi, T., Shishido, T., and Hanafusa, H. (1999) The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc. Natl. Acad. Sci. U.S.A. 96, 10182-10187.
36. Georgescu, M.M., Kirsch, K.H., Kaloudis, P., Yang, H., Pavletich, N.P., and Hanafusa, H. (2000) Stabilization and productive positioning roles of the C2 domain of Pten tumor suppressor. Cancer Res. 60, 7033-7038.
37. Gescher, A. (1998) Analogs of staurosporine: Potential anticancer drugs? Gen. Pharmacol. 31, 721-728.
38. Gimm, O., Attie-Bitach, T., Lees, J.A., Vekemans, M., and Eng, C. (2000a) Expression of the Pten tumor suppressor protein during human development. Hum. Mol Genet. 9, 1633-1639.
39. Gimm, O., Perren, A., Weng, L.P., Marsh, D.J., Yeh, J.J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J.A., Mutter, G.L., Robinson, B.G., Komminoth, P., Dralle, H., and Eng, C. (2000b) Differential nuclear and cytoplasmic expression of Pten in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol. 156, 1693-1700.
40. Giri, D., and Ittmann, M. (1999) Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum. Pathol. 30, 419-424.
41. Kip1 is required for Pten-induced G1 growth arrest. Cancer Res. 61, 2105-2111.
42. Groszer, M., Erickson, R., Scripture-Adams, D., Lesche, R., Trumpp, A., Zack, J.A., Kornblum, H.I., Liu, X., and Wu, H. (2001) Negative regulation of neural stem/progenitor cell proliferation by the PTEN tumor suppressor gene in vivo. Science 294, 2186-2189.
43. Gu, J., Tamura, M., and Yamada, K.M. (1998) Tumor suppressor Pten inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol. 143, 1375-1383.
44. Gu, J., Tamura, M., Pankov, R., Danen, E.H., Takino, T., Matsumoto, K., and Yamada, K.M. (1999) Shc and FAK differentially regulate cell motility and directionality modulated by Pten. J. Cell Biol. 146, 389-403.
45. Guipponi, M., Tapparel, C., Jousson, O., Scamuffa, N., Mas, C., Rossier, C., Hutter, P., Meda, P., Lyle, R., Reymond, A., and Antonarakis, S.E. (2001) The murine orthologue of the Golgi-localized TPTE protein provides clues to the evolutionary history of the human TPTE gene family. Hum. Genet. 109, 569-575.
46. Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., and Stokoe, D. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol. 8, 1195-1198.
47. He, J., Mokhtari, K., Sanson, M., Marie, Y., Kujas, M., Huguet, S., Leuraud, P., Capelle, L., Delattre, J.Y., Poirier, J., and Hoang-Xuan, K. (2001) Glioblastomas with an oligodendroglial component: A pathological and molecular study. J. NeuropathoL Exp. Neurol. 60, 863-871.
48. Hidalgo, M., and Rowinsky, E.K. (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19, 6680-6686.
49. Hill, M.M., Andjelkovic, M., Brazil, D.P., Ferrari, S., Fabbro, D., and Hemmings, B.A. (2001) Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J. Biol. Chem. 276, 25643-25646.
50. Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E., and Fuller, G.N. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 25, 55-57.
51. Hui, A.B., Lo, K.W., Yin, X.L., Poon, W.S., and Ng, H.K. (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab. Invest. 81, 717-723.
52. Jiang, B.H., Jiang, G., Zheng, J.Z., Lu, Z., Hunter, T., and Vogt, P.K. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363-369.
53. Jones, G., Machado, J., Jr., Tolnay, M., and Merlo, A. (2001a) Pten-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res. 61, 5688-5691.
54. Jones, G., Machado, J., Jr., and Merlo, A. (2001b) Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res. 61, 4978-4981.
55. Kato, H., Kato, S., Kumabe, T., Sonoda, Y., Yoshimoto, T., Kato, S., Han, S.Y., Suzuki, T., Shibata, H., Kanamaru, R., and Ishioka, C. (2000) Functional evaluation of p53 and PTEN gene mutations in gliomas. Clin. Cancer Res. 6, 3937-3943.
56. Knobbe, C.B., and Reifenberger, G. (2001) Molecular genetic analysis of human glioblastomas for aberrations of genes encoding members of the Pten/P13K/Akt signal transduction pathway. Neuro-Oncology [serial online], Doc. A153, September 24, 2001. URL . Neuro-Oncology 3, 304. (Abstract)
57. Kotelevets, L., van Hengel, J., Bruyneel, E., Mareel, M., van Roy, F., and Chastre, E. (2001) The lipid phosphatase activity of Pten is critical for stabilizing intercellular junctions and reverting invasiveness. J. Cell Biol. 155, 1129-1135.
58. Koul, D., Parthasarathy, R., Shen, R., Davies, M.A., Jasser, S.A., Chintala, S.K., Rao, J.S., Sun, Y., Benvenisite, E.N., Liu, T.J., and Yung, W.K. (2001) Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20, 6669-6678.
59. Kraus, J.A., Lamszus, K., Glesmann, N., Beck, M., Wolter, M., Sabel, M., Krex, D., Klockgether, T., Reifenberger, G., and Schlegel, U. (2001) Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol. 101, 311-320.
60. Kubiatowski, T., Jang, T., Lachyankar, M.B., Salmonsen, R., Nabi, R.R., Quesenberry, P.J., Litofsky, N.S., Ross, A.H., and Recht, L.D. (2001) Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J. Neurosurg. 95, 480-488.
61. Kubota, N., Okada, S., Inada, T., Ohnishi, K., and Ohnishi, T. (2000) Wortmannin sensitizes human glioblastoma cell lines carrying mutant and wild type TP53 gene to radiation. Cancer Lett. 161, 141-147.
62. Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G., Burger, P.C., and Baker, S.J. (2001) Pten regulates neuronal soma size: A mouse model of Lhermitte-Duclos disease. Nat. Genet. 29, 404-411.
63. Lachyankar, M.B., Sultana, N., Schonhoff, C.M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P.J., Litofsky, N.S., Recht, L.D., Nabi, R., Miller, S.J., Ohta, S., Neel, B.G., and Ross, A.H. (2000) A role for nuclear Pten in neuronal differentiation. J. Neurosci. 20, 1404-1413.
64. Lee, J.O., Yang, H., Georgescu, M.M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J.E., Pandolfi, P., and Pavletich, N.P. (1999) Crystal structure of the Pten tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334.
65. Li, D.M., and Sun, H. (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57, 2124-2129.
66. Li, D.M., and Sun, H. (1998) Pten/MMAC1/Tep1 suppresses the tumor-igenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 95, 15406-15411.
67. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R. (1997) PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
68. Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M.P., Tonks, N., and Parsons, R. (1998) The Pten/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58, 5667-5672.
69. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., and Parsons, R. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64-67.
70. Liliental, J., Moon, S.Y., Lesche, R., Mamillapalli, R., Li, D., Zheng, Y., Sun, H., and Wu, H. (2000) Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10, 401-404.
71. Lin, H., Bondy, M.L., Langford, L.A., Hess, K.R., Delclos, G.L., Wu, X., Chan, W., Pershouse, M.A., Yung, W.K., and Steck, P.A. (1998) Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance. Clin. Cancer Res. 4, 2447-2454.
72. Liu, W., James, C.D., Frederick, L., Alderete, B.E., and Jenkins, R.B. (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57, 5254-5257.
73. Ma, Y.Y., Wei, S.J., Lin, YC., Lung, J.C., Chang, T.C., Whang-Peng, J., Liu, J.M., Yang, D.M., Yang, W.K., and Shen, C.Y. (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19, 2739-2744.
74. Maehama, T., and Dixon, J.E. (1998) The tumor suppressor, Pten/Mmac1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
75. Maehama, T., Taylor, G.S., and Dixon, J.E. (2001) Pten and myotubularin: Novel phosphoinositide phophatases. Annu. Rev. Biochem. 70, 247-279.
76. Maier, D., Zhang, Z., Taylor, E., Hamou, M.F., Gratzl, O., Van Meir, E.G., Scott, R.J., and Merlo, A. (1998) Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 16, 3331-3335.
77. Maier, D., Jones, G., Li, X., Schonthal, A.H., Gratzl, O., Van Meir, E.G., and Merlo, A. (1999) The Pten lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. 59, 5479-5482.
78. Maity, A., Pore, N., Lee, J., Solomon, D., and O'Rourke, D.M. (2000) Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res. 60, 5879-5886.
79. Maity, A., Pore, N., Haas-Kogan, D.A., and O'Rourke, D.M. (2001) PTEN mutation cooperates with EGFR activation in human glioblastoma cells to increase VEGF mRNA levels by transactivating an element in the proximal promoter. Int J. Radiat Oncol. Biol. Phys. 51 (Suppl. 1), 101-102.
80. Malmer, B., Gronberg, H., Andersson, U., Jonsson, B.A., and Henriksson, R. (2001) Microsatellite instability, PTEN and p53 germline mutations in glioma families. Acta Oncol. 40, 633-637.
81. Mamillapalli, R., Gavrilova, N., Mihaylova, V.T., Tsvetkov, L.M., Wu, H., Zhang, H., and Sun, H. (2001) Pten regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr. Biol. 11, 263-267.
82. Marsh, D.J., Dahia, P.L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R.J., and Eng, C. (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16, 333-334.
83. Marsh, D.J., Kum, J.B., Lunetta, K.L., Bennett, M.J., Gorlin, R.J., Ahmed, S.F., Bodurtha, J., Crowe, C., Curtis, M.A., Dasouki, M., Dunn, T., Feit, H., Geraghty, M.T., Graham, J.M, Jr., Hodgson, S.V., Hunter, A., Korf, B.R., Manchester, D., Miesfeldt, S., Murday, V.A., Nathanson, K.L., Parisi, M., Pober, B., Romano, C., Eng, C., et al. (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 8, 1461-1472.
84. Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K., and Donner, D.B. (2002) Pten protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484-5489.
85. Medema, R.H., Kops, G.J., Bos, J.L., and Burgering, B.M. (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782-787.
86. Mills, G.B., Lu, Y.L., and Kohn, E.C. (2001) Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo. Proc. Natl. Acad Sci. U.S.A. 98, 10031-10033.
87. Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., and Sellers, W.R. (2000) Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of Pten. Mol. Cell. Biol. 20, 8969-8992.
88. Nave, B.T., Ouwens, M., Withers, D.J., Alessi, D.R., and Shepherd, P.R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427-431.
89. Neshat, M.S., Mellinghoff, I.K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J.J., Wu, H., and Sawyers, C.L. (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. U.S.A. 98, 10314-10319.
90. Ng, S.S., Tsao, M.S., Nicklee, T., and Hedley, D.W. (2001) Wortmannin inhibits PKB/Akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clin. Cancer Res. 7, 3269-3275.
91. Olschwang, S., Serova-Sinilnikova, O.M., Lenoir, G.M., and Thomas, G. (1998) PTEN germ-line mutations in juvenile polyposis coli. Nat. Genet. 18, 12-14.
92. Paramio, J.M., Navarro, M., Segrelles, C., Gomez-Casero, E., and Jorcano, J.L. (1999) Pten tumor suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 18, 7462-7468.
93. Peraud, A., Watanabe, K., Schwechheimer, K., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1999) Genetic profile of the giant cell glioblastoma. Lab. Invest. 79, 123-129.
94. Persad, S., Troussard, A.A., McPhee, T.R., Mulholland, D.J., and Dedhar, S. (2001) Tumor suppressor Pten inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1 -mediated transcriptional activation. J. Cell Biol. 153, 1161-1174.
95. Piva, R., Cavalla, P., Bortolotto, S., Cordera, S., Richiardi, P., and Schiffer, D. (1997) p27/kip1 expression in human astrocytic gliomas. Neurosci. Lett. 234, 127-130.
96. Podsypanina, K., Ellenson, L.H., Nemes, A., Gu, J., Tamura, M., Yamada, K.M., Cordon-Cardo, C., Catoretti, G., Fisher, P.E., and Parsons, R. (1999) Mutation of PTEN/MMAC1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. U.S.A. 96, 1563-1568.
97. +/- mice. Proc. Natl. Acad. Sci. U.S.A. 98, 10320-10325.
98. Powis, G., Bonjouklian, R., Berggren, M.M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W.F., Dodge, J., and Grindey, G. (1994) Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54, 2419-2423.
99. Radimerski, T., Montagne, J., Rintelen, F., Stocker, H., van der Kaay, J., Downes, C.P., Hafen, E., and Thomas, G. (2002) dS6K regulated cell growth is dPKB/dPI3K independent, but requires dPDK1. Nat. Cell Biol. 4, 251-255.
100. Raffel, C., Frederick, L., O'Fallon, J.R., Atherton-Skaff, P., Perry, A., Jenkins, R.B., and James, C.D. (1999) Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin. Cancer Res. 5, 4085-4090.
101. Rasheed, B.K., Stenzel, T.T., McLendon, R.E., Parsons, R., Friedman, A.H., Friedman, H.S., Bigner, D.D., and Bigner, S.H. (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 57, 4187-4190.
102. Reis, R.M., Konu-Lebleblicioglu, D., Lopes, J.M., Kleihues, P., and Ohgaki, H. (2000) Genetic profile of gliosarcomas. Am. J. Pathol. 156, 425-432.
103. Salvesen, H.B., MacDonald, N., Ryan, A., Jacobs, I.J., Lynch, E.D., Akslen, L.A., and Das, S. (2001) PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int. J. Cancer 91, 22-26.
104. Sano, T., Lin, H., Chen, X., Langford, L.A., Koul, D., Bondy, M.L., Hess, K.R., Myers, J.N., Hong, Y.K., Yung, W.K., and Steck, P.A. (1999) Differential expression of MMAC/Pten in glioblastoma multiforme: Relationship to localization and prognosis. Cancer Res. 59, 1820-1824.
105. Sasaki, H., Zlatescu, M.C., Betensky, R.A., Ino, Y., Caimcross, J.G., and Louis, D.N. (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am. J. Pathol. 159, 359-367.
106. Scheid, M.P., and Woodgett, J.R. (2001) PKB/AKT: Functional insights from genetic models. Nat. Rev. Mol. Cell Biol. 2, 760-768.
107. Schmelzle, T., and Hall, M.N. (2000) TOR, a central controller of cell growth. Cell 103, 253-262.
108. Schmidt, E.E., Ichimura, K., Goike, H.M., Moshref, A., Liu, L., and Collins, V.P. (1999) Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. J. Neuropathol. Exp. Neurrol. 58, 1170-1183.
109. Sekulic, A., Hudson, C.C., Homme, J.L., Yin, P., Otterness, D.M., Karnitz, L.M., and Abraham, R.T. (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60, 3504-3513.
110. Sharrard, R.M., and Maitland, N.J. (2000) Alternative splicing of the human PTEN/MMAC1/TEP1 gene. Biochim. Biophys. Acta 1494, 282-285.
111. Shayesteh, L., Lu, Y., Kuo, W.L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G.B., and Gray, J.W. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99-102.
112. Simpson, L., and Parsons, R. (2001) Pten: Life as a tumor suppressor. Exp. Cell Res. 264, 29-41.
113. Smith, J.S., Tachibana, I., Passe, S.M., Huntley, B.K., Borell, T.J., Iturria, N., O'Fallon, J.R., Schaefer, P.L., Scheithauer, B.W., James, C.D., Buckner, J.C., and Jenkins, R.B. (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J. Natl. Cancer Inst. 93, 1246-1256.
114. Sonoda, Y., Ozawa, T., Aldape, K.D., Deen, D.F., Berger, M.S., and Pieper, R.O. (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 61, 6674-6678.
115. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P., and Mak, T.W. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor Pten. Cell 95, 29-39.
116. Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., and Mak, TW (2001) Regulation of PTEN transcription by p53. Mol Cell 8, 317-325.
117. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D.H., and Tavtigian, S.V. (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 1Oq23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362.
118. Stein, R.C. (2001) Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr. Relat. Cancer 8, 237-248.
119. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M., and Mak, T.W. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169-1178.
120. Suzuki, A., Yamaguchi, M.T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., Tsubata, T., Ohashi, P.S., Koyasu, S., Penninger, J.M., Nakano, T., and Mak, T.W. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534.
121. Tachibana, I., Smith, J.S., Sato, K., Hosek, S.M., Kimmel, D.W., and Jenkins, R.B. (2000) Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am. J. Med. Genet. 92, 136-141.
122. Tada, K., Shiraishi, S., Kamiryo, T., Nakamura, H., Hirano, H., Kuratsu, J., Kochi, M., Saya, H., and Ushio, Y. (2001) Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: Correlation with patient age and survival. J. Neurosurg. 95, 651-659.
123. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K.M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor Pten. Science 280, 1614-1617.
124. Tamura, M., Gu, J., Takino, T., and Yamada, K.M. (1999) Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59, 442-449.
125. Tian, X.X., Pang, J.C., To, S.S., and Ng, H.K. (1999) Restoration of wild-type Pten expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J. Neuropathol. Exp. Neurol. 58, 472-479.
126. Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J. Neuropathol. Exp. Neurol. 57, 684-689.
127. Tolkacheva, T., and Chan, A.M. (2000) Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene. Oncogene 119, 680-689.
128. Torres, J., and Pulido R. (2001) The tumor suppressor Pten is phosphorylated by the protein kinase CK2 at its C terminus: Implications for Pten stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993-998.
129. Tortosa, A., Ino, Y., Odell, N., Swilley, S., Sasaki, H., Louis, D.N., and Henson, J.W. (2000) Molecular genetics of radiographically defined de novo glioblastoma multiforme. Neuropathol. Appl. Neurobiol. 26, 544-552.
130. Vanhaesebroeck, B., and Alessi, D.R. (2000) The PI3K-PDK1 connection: More than just a road to PKB. Biochem. J. 346, 561-576.
131. Vazquez, F., Grossman, S.R., Takahashi, Y., Rokas, M.V., Nakamura, N., and Sellers, W.R. (2001) Phosphorylation of the Pten tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627-48630.
132. Virolle, T., Adamson, E.D., Baron, V., Birle, D., Mercola, D., Mustelin, T., and de Belle, I. (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3, 1124-1128.
133. Vlahos, C.J., Matter, W.F., Hui, K.Y., and Brown, R.F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
134. Walker, C., Joyce, K.A., Thompson-Hehir, J., Davies, M.P., Gibbs, F.E., Halliwell, N., Lloyd, B.H., Machell, Y., Roebuck, M.M., Salisbury, J., Sibson, D.R., Du Plessis, D., Broome, J., and Rossi, M.L. (2001) Characterisation of molecular alterations in microdissected archival gliomas. Acta Neuropathol. 101, 321-333.
135. Walker, S.M., Downes, C.P., and Leslie, N.R. (2001) TPIP: A novel phosphoinositide 3-phosphatase. Biochem. J. 360, 277-283.
136. Wang, D., Huang, H.J., Kazlauskas, A., and Cavenee, W.K. (1999) Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 59, 1464-1472.
137. Wang, S.I., Puc, J., Li, J., Bruce, J.N., Cairns, P., Sidransky, D., and Parsons, R. (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57, 4183-4186.
138. Watanabe, K., Peraud, A., Gratas, C., Wakai, S., Kleihues, P., and Ohgaki, H. (1998) p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol. 95, 559-564.
139. Wen, S., Stolarov, J., Myers, M.P., Su, J.D., Wigler, M.H., Tonks, N.K., and Durden, D.L. (2001) Pten controls tumor-induced angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 98, 4622-4627.
140. Weng, L.P., Smith, W.M., Brown, J.L., and Eng, C. (2001a) Pten inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum. Mol. Genet. 10, 605-616.
141. Weng, L.P., Brown, J.L., and Eng, C. (2001b) Pten coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum. Mol. Genet. 10, 599-604.
142. Whang, Y.E., Wu, X., Suzuki, H., Reiter, R.E., Tran, C., Vessella, R.L., Said, J.W., Isaacs, W.B., and Sawyers, C.L. (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad Sci. U.S.A. 95, 5246-5250.
143. Wick, W., Furnari, F.B., Naumann, U., Cavenee, W.K., and Weller, M. (1999) PTEN gene transfer in human malignant glioma: Sensitization to irradiation and CD95L-induced apoptosis. Oncogene 18, 3936-3943.
144. Wiestler, O.D., Padberg, G.W., and Steck, P.A. (2000) Cowden disease and dysplastic gangliocytoma of the cerebellum/Lhermitte-Duclos disease. In: Kleihues, P., and Cavenee, W.K. (Eds.), Pathology and Genetics of Tumours of the Nervous System. WHO Classification of Tumors. Lyon, France: IARC Press. pp. 235-237.
145. WAF1 by Pten/MMAC1 tumor suppressor. Mol. Cell. Biochem. 203, 59-71.
146. Wu, X., Senechal, K., Neshat, M.S., Whang, Y.E., and Sawyers, C.L. (1998) The Pten/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl. Acad. Sci. U.S.A. 95, 15587-15591.
147. Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M.B., Yuan, X.J., Wood, J., Ross, C., Sawyers, C.L., and Whang, YE. (2000) Evidence for regulation of the Pten tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl. Acad. Sci. U.S.A. 97, 4233-4238.
148. Wu, Y., Dowbenko, D., Spencer, S., Laura, R., Lee, J., Gu, Q., and Lasky, L.A. (2000) Interaction of the tumor suppressor Pten/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J. Biol. Chem. 275, 21477-21485.
149. Wu, Y., Dowbenko, D., Pisabarro, M.T., Dillard-Telm, L., Koeppen, H., and Lasky, L.A. (2001) Pten 2, a Golgi-associated testis-specific homologue of the Pten tumor suppressor lipid phosphatase. J. Biol. Chem. 276, 21745-21753.
150. Yamada, K.M., and Araki, M. (2001) Tumor suppressor Pten: Modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 114, 2375-2382.
151. Yart, A., Laffargue, M., Mayeux, P., Chretien, S., Peres, C., Tonks, N., Roche, S., Payrastre, B., Chap, H., and Raynal, P. (2001) A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J. Biol. Chem. 276, 8856-8864.
152. Zhang, C.L., Tada, M., Kobayashi, H., Nozaki, M., Moriuchi, T., and Abe, H. (2000) Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay. Oncogene 19, 4346-4353.
153. Zhang, W., Yamada, H., Sakai, N., and Nozawa, Y. (1993) Sensitization of C6 glioma cells to radiation by staurosporine, a potent protein kinase C inhibitor. J. Neurooncol. 15, 1-7.
154. Zhou, B.P., Liao, Y., Xia, W., Zou, Y., Spohn, B., and Hung, M.C. (2001a) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3, 973-982.
155. Zhou, B.P., Liao, Y., Xia, W., Spohn, B., Lee, M.H., and Hung, M.C. (2001b) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3, 245-252.
156. Zhou, X.P., Li, Y.J., Hoang-Xuan, K., Laurent-Puig, P., Mokhtari, K., Longy, M., Sanson, M., Delattre, J.Y., Thomas, G., and Hamelin, R. (1999a) Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations. Int. J. Cancer 84, 150-154.
157. Zhou, X.P., Sanson, M., Hoang-Xuan, K., Robin, E., Taillandier, L., He, J., Mokhtari, K., Cornu, R., Delattre, J.Y., Thomas, G., and Hamelin, R. (1999b) Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Francaise. Ann. Neurol. 46, 913-916.
158. Zhou, X.-P., Hampel, H., Thiele, H., Gorlin, R.J., Hennekam, R.C.M., Parisi, M., Winter, R.M., and Eng, C. (2001) Association of germline mutation in the PTEN tumor suppressor gene and Proteus and Proteus-like syndromes. Lancet 358, 210-211.
159. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B., Stokoe, D., and Giaccia, A.J. (2000) Loss of Pten facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396.